2005 Volume 44 Issue 4 Pages 205-209
Objective: Cytologic screening for endometrial cancer has been indicated only for women meeting certain conditions in uterine cervical screening. It is unknown, however, whether qualifications for corpus screening remain suitable under recent conditions in public health examination. To evaluate whether cytopathological screening for endometrial cancer should be done as part of the public health examination, we reviewed the results of cytopatholgical examination in Sakai City for the last 16 years.
Study Design: We studied check-up forms, cytodiagnosis results, and follow-up survey results for 14, 188 women undergoing cytopathological screening for endometrial cancer in public health examinations between 1987 and 2002.
Results: The percentage of women examined accounted for 5.7%, of whom 1.8% were cytologically identified as needing a biopsy. Afurther, 0.25% were diagnosed as having endometrial cancer. If the qualifications for cytopathologic uterine corpus screening were tentatively limited to those meeting all of the following conditions, however, i. e., over 50 years of age, postmenopausal, and having atypical genital bleeding in the last 6 months, both corpus screening and endometrial cancer detection would be more suited to the trial value calculated at the start of the cyotologic screening program for endometrial cancer as part of the public health examination.
Conclusion: Our results suggest that new qualifications, including limited indications, should be considered for cost effectiveness in cytological examination programs for endometrial cancer screening.
